DPH.L

Dechra Pharmaceuticals PLC [DPH.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

DPH.L Stock Summary

In the News

DPH.L Financial details

Company Rating
Buy
Market Cap
4.4B
Income
-27.9M
Revenue
761.5M
Book val./share
6.63
Cash/share
0.65
Dividend
0.13
Dividend %
0%
Employees
2.46K
Optionable
No
Shortable
Yes
Earnings
26 Feb 2024
P/E
-157.58
Forward P/E
3681.9
PEG
10.89
P/S
5.78
P/B
5.82
P/C
5947.69
P/FCF
107.82
Quick Ratio
0.45
Current Ratio
2.85
Debt / Equity
0.67
LT Debt / Equity
0.66
-
-
EPS (TTM)
-0.24
EPS next Y
1.05
EPS next Q
-
EPS this Y
-144.44%
EPS next Y
-534.92%
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
9.59%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
0.66%
SMA50
2.07%
SMA100
-
Inst Own
0.12%
Inst Trans
0.23%
ROA
-2%
ROE
-6%
ROC
0.01%
Gross Margin
56%
Oper. Margin
2%
Profit Margin
-4%
Payout
-185%
Shs Outstand
113.91M
Shs Float
112.53M
-
-
-
-
Target Price
-
52W Range
0.0-4145.837
52W High
-
52W Low
-
RSI
71.62
Rel Volume
4.79
Avg Volume
1.36M
Volume
6.53M
Perf Week
0.26%
Perf Month
1.1%
Perf Quarter
-
Perf Half Y
1.63%
-
-
-
-
Beta
0.781
-
-
Volatility
2.39%, 12.56%
Prev Close
0.05%
Price
3866
Change
0%

DPH.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-06-30

Metric History 2019-06-302020-06-302021-06-302022-06-30 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
4.694.985.596.266.67
Net income per share
0.30.330.510.53-0.24
Operating cash flow per share
0.81.030.821.130.56
Free cash flow per share
0.580.55-0.420.420.29
Cash per share
0.782.21.091.110.65
Book value per share
4.956.165.826.126.62
Tangible book value per share
-1.73-0.53-0.76-0.58-1.47
Share holders equity per share
4.956.165.826.126.62
Interest debt per share
3.13.543.023.134.81
Market cap
2.83B2.95B4.75B3.77B4.21B
Enterprise value
3.06B3.07B4.95B3.98B4.64B
P/E ratio
91.5986.8885.6364.76-150.74
Price to sales ratio
5.875.727.825.535.52
POCF ratio
34.627.6853.3430.6766.12
PFCF ratio
47.7251.49-103.9983.2126.29
P/B Ratio
5.564.627.515.655.57
PTB ratio
5.564.627.515.655.57
EV to sales
6.355.978.155.836.09
Enterprise value over EBITDA
24.9423.4630.5715.6947.25
EV to operating cash flow
37.3828.8855.5832.3672.89
EV to free cash flow
51.5753.72-108.3787.79139.21
Earnings yield
0.010.010.010.02-0.01
Free cash flow yield
0.020.02-0.010.010.01
Debt to equity
0.610.560.50.490.67
Debt to assets
0.290.290.260.250.32
Net debt to EBITDA
1.860.971.240.824.38
Current ratio
2.473.272.522.82.85
Interest coverage
3.714.548.577.830.14
Income quality
2.12.041.061.2910.1
Dividend Yield
0.010.010.010.010.01
Payout ratio
0.920.980.680.77-1.85
Sales general and administrative to revenue
0.260.260.250.260.47
Research and developement to revenue
0.050.060.050.050.08
Intangibles to total assets
0.660.560.590.560.59
Capex to operating cash flow
-0.28-0.46-1.51-0.63-0.48
Capex to revenue
-0.05-0.1-0.22-0.11-0.04
Capex to depreciation
-2.3-3.46-8.7-0.87-0.34
Stock based compensation to revenue
00000
Graham number
5.796.748.178.576.03
ROIC
0.050.040.070.070
Return on tangible assets
0.090.060.110.1-0.04
Graham Net
-3.3-2.44-2.96-2.99-4.58
Working capital
174M311.6M236.4M285.7M303.9M
Tangible asset value
-177.9M-54.7M-82.9M-63.7M-167.2M
Net current asset value
-247.3M-151.2M-189M-182.1M-346.3M
Invested capital
0.610.560.50.490.67
Average receivables
45.55M85.25M83.8M105.15M133.15M
Average payables
85.6M96.85M105.85M125.15M140.65M
Average inventory
95.3M112.4M135.15M162.6M196.5M
Days sales outstanding
69.0256.2652.9565.3769.12
Days payables outstanding
167.02160.37158.06168.12157.35
Days of inventory on hand
181.89197.28208.19215.93236.62
Receivables turnover
5.296.496.895.585.28
Payables turnover
2.192.282.312.172.32
Inventory turnover
2.011.851.751.691.54
ROE
0.060.050.090.09-0.04
Capex per share
-0.22-0.48-1.24-0.71-0.27

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q4

Metric History 2022-06-302022-09-302022-12-312023-03-31 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.61.661.661.691.69
Net income per share
0.080.10.1-0.22-0.22
Operating cash flow per share
0.160.230.230.050.05
Free cash flow per share
0.120.180.1800
Cash per share
1.110.770.770.650.65
Book value per share
6.117.397.396.636.63
Tangible book value per share
-0.58-2.37-2.37-1.42-1.47
Share holders equity per share
6.117.397.396.636.63
Interest debt per share
3.044.44.534.344.49
Market cap
3.77B2.98B2.98B3.02B4.2B
Enterprise value
3.98B2.9B3.4B2.94B4.63B
P/E ratio
107.7766.0365.93-29.87-41.55
Price to sales ratio
21.5915.8215.7915.7121.85
POCF ratio
216.79115.9115.72498.72693.69
PFCF ratio
293.55145.58145.36-30.17K-41.97K
P/B Ratio
5.663.553.5445.56
PTB ratio
5.663.553.5445.56
EV to sales
22.7815.3518.0415.3224.09
Enterprise value over EBITDA
112.44104.38122.64878.461.38K
EV to operating cash flow
228.75112.49132.16486.42764.78
EV to free cash flow
309.75141.3166.01-29.43K-46.27K
Earnings yield
000-0.01-0.01
Free cash flow yield
00.010.0100
Debt to equity
0.490.590.610.650.67
Debt to assets
0.250.280.290.310.32
Net debt to EBITDA
5.88-3.1715.25-22.21128.39
Current ratio
2.82.732.732.852.85
Interest coverage
8.535.275.27-2.22-2.22
Income quality
1.992.282.28-0.24-0.24
Dividend Yield
00.010.0100
Payout ratio
0.741.651.65-0.28-0.28
Sales general and administrative to revenue
00000
Research and developement to revenue
0.160.070.070.160.16
Intangibles to total assets
0.560.640.640.580.59
Capex to operating cash flow
-0.26-0.2-0.2-1.02-1.02
Capex to revenue
-0.03-0.03-0.03-0.03-0.03
Capex to depreciation
-0.25-1.22-1.22-0.3-0.3
Stock based compensation to revenue
0.0100-0.01-0.01
Graham number
3.324.064.065.755.75
ROIC
0.010.010.01-0.01-0.01
Return on tangible assets
0.020.020.02-0.04-0.04
Graham Net
-3.83-5.34-5.34-4.59-4.59
Working capital
285.7M290.9M290.9M303.9M303.9M
Tangible asset value
-63.7M-269.5M-269.5M-162.1M-167.2M
Net current asset value
-182.1M-443.3M-443.3M-346.3M-346.3M
Invested capital
0.490.590.610.650.67
Average receivables
062.95M125.9M135.05M144.2M
Average payables
91.4M138.05M139.3M91.35M93.95M
Average inventory
175.7M199.75M223.8M220.55M217.3M
Days sales outstanding
060.0560.0567.5867.58
Days payables outstanding
160.63157.8157.845.16150.35
Days of inventory on hand
206.3253.52253.52226.09226.09
Receivables turnover
01.51.51.331.33
Payables turnover
0.560.570.571.990.6
Inventory turnover
0.440.360.360.40.4
ROE
0.010.010.01-0.03-0.03
Capex per share
-0.04-0.05-0.05-0.05-0.05

DPH.L Frequently Asked Questions

What is Dechra Pharmaceuticals PLC stock symbol ?

Dechra Pharmaceuticals PLC is a GB stock and trading under the symbol DPH.L

What is Dechra Pharmaceuticals PLC stock quote today ?

Dechra Pharmaceuticals PLC stock price is $3866 today.

Is Dechra Pharmaceuticals PLC stock public?

Yes, Dechra Pharmaceuticals PLC is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Check Those
Similar Market Cap